VINAPHARM | APEA - Asia Pacific Enterprise Awards Asia Pacific Enterprise Awards
parallax background

MASTER ENTREPRENEUR CATEGORY

HAN THI KHANH VINH
CEO

Information about the Entrepreneur
Ms. Han Thi Khanh Vinh, a distinguished businesswoman known for her strategic insight and diplomatic finesse, is the driving force behind Vietnam Pharmaceutical Corporation's (Vinapharm) remarkable growth. As the company's CEO, she has spearheaded numerous initiatives to elevate Vinapharm's status as a leading pharmaceutical player in Vietnam and beyond.

Born in 1975, Ms. Vinh has a solid educational background. She graduated with a Bachelor's degree in Economics, specializing in Accounting from the National Economics University. She further advanced her education by earning a Master's Degree in International Accounting from Swinburne University of Technology in Melbourne, Australia.

Ms. Vinh has been dedicated to the pharmaceutical industry for over 7 years, during which she has faced and overcome numerous challenges. One significant obstacle was navigating the complex financial and regulatory landscapes to ensure Vinapharm's compliance and growth after the equitization period. As CEO of a holding company in the pharmaceutical sector, Ms.Vinh's contribution during these times has been pivotal, leveraging her strategic vision and financial expertise to steer the company through various industry challenges.

Her story is not only about professional success but also about a lifelong commitment to advancing the pharmaceutical industry in Vietnam and ensuring that quality healthcare products are accessible to all.

Other Interesting Facts about the Entrepreneur
Han Thi Khanh Vinh is a visionary leader with a determined goal to drive Vinapharm to new heights. With a strong background in finance and over 7 years of industry experience, she has steered Vinapharm through complex financial and regulatory challenges.

Her success is built on relentless dedication, strategic thinking, and a commitment to excellence. Ms. Vinh emphasizes integrity, perseverance, and continuous learning, believing in transparency and ethical business practices.

Outside of work, she enjoys reading, traveling, and maintaining a healthy work-life balance through fitness.

Company Achievements & Role as Entrepreneur
Under the leadership of Ms. Vinh, Vinapharm and its subsidiaries have achieved a number of significant achievements.

Vinapharm has undergone a strong transformation, restructuring its governance, expanding and developing partnerships with foreign partners, and contributing to strengthening its position as the only corporation in Vietnam’s pharmaceutical industry with controlling shares held by a state-owned enterprise.

Besides that, the Vinapharm restructuring plan, which includes major strategic directions, was approved by the company's annual General Meeting of Shareholders on April 23, 2024. Following this approved plan, Vinapharm has streamlined its organizational structure, eliminating inefficient activities to focus resources on more productive operations. The company has also developed a strategy to optimize its capital investments in various businesses.

Another of its implemented changes is in its organizational management and operational model, following the structure of a General Meeting of Shareholders, a Board of Directors, and a Chief Executive Officer. Within this model, at least 20% of the Board of Directors are independent members and an Audit Committee is established under the Board to enhance Vinapharm's operational efficiency, thereby empowering the Board with better control and improving corporate governance.

In 2023, Vinapharm's revenue and pre-tax profit grew by 76% and 708%, respectively, compared to 2022. The business performance for the first six months of 2024, according to Vinapharm's consolidated financial report, also showed strong growth, with an 18% increase in revenue and a 15% increase in pre-tax profit compared to the same period last year, reaching 72% of the annual revenue target and 86% of the pre-tax profit target set for 2024.

In addition to its production and business tasks, Vinapharm has for more than 50 years, consistently fulfilled public welfare tasks assigned by the Government and the Ministry of Health. This includes implementing measures to ensure social security and the storing, transporting, and distributing of drugs under the national reserve program; thus, preventing diseases, and providing essential drugs for programs, objectives, and social policies, especially in remote and mountainous areas.

Ms. Han Thi Khanh Vinh has played a pivotal role in setting strategic directions and guiding departments to achieve these successes, laying a solid foundation for Vinapharm's future development.

Vision, Mission, & Future Plans
Ms. Han Thi Khanh Vinh envisions Vinapharm as a leading corporation in the pharmaceutical industry, optimizing drug distribution networks and fostering strategic partnerships to enhance drug accessibility and affordability. Her mission is to build a robust and resilient pharmaceutical distribution platform while driving innovation in the healthcare industry.

To achieve these goals, Ms. Vinh has outlined a strategic roadmap for Vinapharm. A key focus is on enhancing the efficiency of the company’s distribution network and procuring high-quality, innovative drugs, and inventory drugs to better serve the healthcare needs of the Vietnamese people.

Moreover, Vinapharm aims to strengthen its position in the pharmaceutical supply chain by collaborating with leading multinational pharmaceutical corporations. A pivotal component of the company's future plans involves establishing a strategic partnership with a foreign investor specializing in biopharmaceuticals. This collaboration aims to facilitate technology transfer and the construction of Vietnam's first biopharmaceutical manufacturing plant.

Ms. Vinh believes that a successful business is one that creates value for its stakeholders while contributing to societal progress. She encourages aspiring entrepreneurs to prioritize building strong partnerships, fostering a culture of innovation, and demonstrating a commitment to social responsibility.

MASTER ENTREPRENEUR CATEGORY

HAN THI KHANH VINH
CEO

Information about the Entrepreneur
Ms. Han Thi Khanh Vinh, a distinguished businesswoman known for her strategic insight and diplomatic finesse, is the driving force behind Vietnam Pharmaceutical Corporation's (Vinapharm) remarkable growth. As the company's CEO, she has spearheaded numerous initiatives to elevate Vinapharm's status as a leading pharmaceutical player in Vietnam and beyond.

Born in 1975, Ms. Vinh has a solid educational background. She graduated with a Bachelor's degree in Economics, specializing in Accounting from the National Economics University. She further advanced her education by earning a Master's Degree in International Accounting from Swinburne University of Technology in Melbourne, Australia.

Ms. Vinh has been dedicated to the pharmaceutical industry for over 7 years, during which she has faced and overcome numerous challenges. One significant obstacle was navigating the complex financial and regulatory landscapes to ensure Vinapharm's compliance and growth after the equitization period. As CEO of a holding company in the pharmaceutical sector, Ms.Vinh's contribution during these times has been pivotal, leveraging her strategic vision and financial expertise to steer the company through various industry challenges.

Her story is not only about professional success but also about a lifelong commitment to advancing the pharmaceutical industry in Vietnam and ensuring that quality healthcare products are accessible to all.

Other Interesting Facts about the Entrepreneur
Han Thi Khanh Vinh is a visionary leader with a determined goal to drive Vinapharm to new heights. With a strong background in finance and over 7 years of industry experience, she has steered Vinapharm through complex financial and regulatory challenges.

Her success is built on relentless dedication, strategic thinking, and a commitment to excellence. Ms. Vinh emphasizes integrity, perseverance, and continuous learning, believing in transparency and ethical business practices.

Outside of work, she enjoys reading, traveling, and maintaining a healthy work-life balance through fitness.
Company Achievements & Role as Entrepreneur
Under the leadership of Ms. Vinh, Vinapharm and its subsidiaries have achieved a number of significant achievements.

Vinapharm has undergone a strong transformation, restructuring its governance, expanding and developing partnerships with foreign partners, and contributing to strengthening its position as the only corporation in Vietnam’s pharmaceutical industry with controlling shares held by a state-owned enterprise.

Besides that, the Vinapharm restructuring plan, which includes major strategic directions, was approved by the company's annual General Meeting of Shareholders on April 23, 2024. Following this approved plan, Vinapharm has streamlined its organizational structure, eliminating inefficient activities to focus resources on more productive operations. The company has also developed a strategy to optimize its capital investments in various businesses.

Another of its implemented changes is in its organizational management and operational model, following the structure of a General Meeting of Shareholders, a Board of Directors, and a Chief Executive Officer. Within this model, at least 20% of the Board of Directors are independent members and an Audit Committee is established under the Board to enhance Vinapharm's operational efficiency, thereby empowering the Board with better control and improving corporate governance.

In 2023, Vinapharm's revenue and pre-tax profit grew by 76% and 708%, respectively, compared to 2022. The business performance for the first six months of 2024, according to Vinapharm's consolidated financial report, also showed strong growth, with an 18% increase in revenue and a 15% increase in pre-tax profit compared to the same period last year, reaching 72% of the annual revenue target and 86% of the pre-tax profit target set for 2024.

In addition to its production and business tasks, Vinapharm has for more than 50 years, consistently fulfilled public welfare tasks assigned by the Government and the Ministry of Health. This includes implementing measures to ensure social security and the storing, transporting, and distributing of drugs under the national reserve program; thus, preventing diseases, and providing essential drugs for programs, objectives, and social policies, especially in remote and mountainous areas.

Ms. Han Thi Khanh Vinh has played a pivotal role in setting strategic directions and guiding departments to achieve these successes, laying a solid foundation for Vinapharm's future development.

Vision, Mission, & Future Plans
Ms. Han Thi Khanh Vinh envisions Vinapharm as a leading corporation in the pharmaceutical industry, optimizing drug distribution networks and fostering strategic partnerships to enhance drug accessibility and affordability. Her mission is to build a robust and resilient pharmaceutical distribution platform while driving innovation in the healthcare industry.

To achieve these goals, Ms. Vinh has outlined a strategic roadmap for Vinapharm. A key focus is on enhancing the efficiency of the company’s distribution network and procuring high-quality, innovative drugs, and inventory drugs to better serve the healthcare needs of the Vietnamese people.

Moreover, Vinapharm aims to strengthen its position in the pharmaceutical supply chain by collaborating with leading multinational pharmaceutical corporations. A pivotal component of the company's future plans involves establishing a strategic partnership with a foreign investor specializing in biopharmaceuticals. This collaboration aims to facilitate technology transfer and the construction of Vietnam's first biopharmaceutical manufacturing plant.

Ms. Vinh believes that a successful business is one that creates value for its stakeholders while contributing to societal progress. She encourages aspiring entrepreneurs to prioritize building strong partnerships, fostering a culture of innovation, and demonstrating a commitment to social responsibility.